Search research articles
Contact Us
Filters
Showing results (841-850 of 962) with videos related to
Page
of 97
Sort By:
European Heart Journal
|
November 17, 2019
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis
Peter R Sinnaeve, Gregory G Schwartz, Daniel M Wojdyla, et al.
The New England Journal of Medicine
|
November 8, 2018
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, et al.
Circulation. Cardiovascular Interventions
|
March 30, 2025
Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients With Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT Trial
Sunil V Rao, Maria Mori Brooks, Helen E A D'Agostino, et al.
Circulation. Cardiovascular Interventions
|
May 24, 2024
Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction
Etienne Puymirat, Guillaume Cayla, Tabassome Simon, et al.
The American Journal of Cardiology
|
October 16, 2020
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)
Hideyuki Kawashima, Mariusz Tomaniak, Masafumi Ono, et al.
The American Journal of Medicine
|
January 3, 2015
Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up
Sami M A Alnasser, Wei Huang, Joel M Gore, et al.
The New England Journal of Medicine
|
November 17, 2020
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Deepak L Bhatt, Michael Szarek, Bertram Pitt, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
June 21, 2019
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54
Mikael Dellborg, Marc P Bonaca, Robert F Storey, et al.
Journal of the American College of Cardiology
|
May 9, 2020
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial
Deepak L Bhatt, Andrew H Briggs, Shelby D Reed, et al.
European Journal of Heart Failure
|
November 7, 2023
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial
Morten Schou, Brian Claggett, Zi Michael Miao, et al.
Page
of 97
Search research articles
Search
Showing results (841-850 of 962) with videos related to
Sort By:
Page
of 97
European Heart Journal
|
November 17, 2019
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis
Peter R Sinnaeve, Gregory G Schwartz, Daniel M Wojdyla, et al.
The New England Journal of Medicine
|
November 8, 2018
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, et al.
Circulation. Cardiovascular Interventions
|
March 30, 2025
Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients With Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT Trial
Sunil V Rao, Maria Mori Brooks, Helen E A D'Agostino, et al.
Circulation. Cardiovascular Interventions
|
May 24, 2024
Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction
Etienne Puymirat, Guillaume Cayla, Tabassome Simon, et al.
The American Journal of Cardiology
|
October 16, 2020
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)
Hideyuki Kawashima, Mariusz Tomaniak, Masafumi Ono, et al.
The American Journal of Medicine
|
January 3, 2015
Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up
Sami M A Alnasser, Wei Huang, Joel M Gore, et al.
The New England Journal of Medicine
|
November 17, 2020
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Deepak L Bhatt, Michael Szarek, Bertram Pitt, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
June 21, 2019
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54
Mikael Dellborg, Marc P Bonaca, Robert F Storey, et al.
Journal of the American College of Cardiology
|
May 9, 2020
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial
Deepak L Bhatt, Andrew H Briggs, Shelby D Reed, et al.
European Journal of Heart Failure
|
November 7, 2023
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial
Morten Schou, Brian Claggett, Zi Michael Miao, et al.
Page
of 97